IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Athyrium Capital Management, LP

Q1 2018 Holdings

Filed 2018-05-15 | 5 holdings | $163.3K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aegerion Pharmaceuticals IncNOTE 2.000% 8/100767EAB8$73.6K$95,045,00045.1%
Vivus IncNOTE 4.500% 5/0928551AB6$44.4K$60,000,00027.2%
PTC Therapeutics IncNOTE 3.000% 8/169366JAB7$43.8K$46,567,00026.8%
Apollo Endosurgery Inc(HQ8F)COM03767D108$1.6K252,0791.0%